During the past decade, CHU NIMES - Unité de Sommeil conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU NIMES - Unité de Sommeil" are "Insomnia Disorder" (2 trials). Many other conditions were trialed in "CHU NIMES - Unité de Sommeil" in a lesser frequency.

Most popular intervention types in "CHU NIMES - Unité de Sommeil" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Daridorexant" (1 trials), "Daridorexant 10 mg" (1 trials), "Daridorexant 25 mg" (1 trials) and "Daridorexant 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU NIMES - Unité de Sommeil" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU NIMES - Unité de Sommeil". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHU NIMES - Unité de Sommeil, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU NIMES - Unité de Sommeil, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".